268 related articles for article (PubMed ID: 9136527)
21. Discrepant 99mTc-ECD images of CBF in patients with subacute cerebral infarction: a comparison of CBF, CMRO2 and 99mTc-HMPAO imaging.
Shishido F; Uemura K; Inugami A; Ogawa T; Fujita H; Shimosegawa E; Nagata K
Ann Nucl Med; 1995 Aug; 9(3):161-6. PubMed ID: 8534592
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of regional cerebral blood flow images by SPECT using xenon-133, iodine-123 IMP, and technetium-99m HM-PAO.
Nakano S; Kinoshita K; Jinnouchi S; Hoshi H; Watanabe K
J Nucl Med; 1989 Feb; 30(2):157-64. PubMed ID: 2786931
[TBL] [Abstract][Full Text] [Related]
23. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of regional cerebral blood flow in hippocampus by 99mTc-ECD SPECT: comparison with 123I-IMP SPECT].
Matsumura K; Watanabe Y; Aoki S; Nakashima H; Maeda H; Hirano T; Takeda K; Nakagawa T
Kaku Igaku; 1996 Sep; 33(9):1021-6. PubMed ID: 8921672
[TBL] [Abstract][Full Text] [Related]
25. Early and delayed brain SPECT with technetium-99m-ECD and iodine-123-IMP in subacute strokes.
Moretti JL; Tamgac F; Weinmann P; Caillat-Vigneron N; Belin CA; Cesaro P; Holman BL; Defer G
J Nucl Med; 1994 Sep; 35(9):1444-9. PubMed ID: 8071689
[TBL] [Abstract][Full Text] [Related]
26. Favorable biodistribution of 99mTc-ECD for brain SPECT comparing with 123I-IMP using alternative body scan.
Hayashida K; Nishimura T; Imakita S; Uehara T
Ann Nucl Med; 1992 Nov; 6(4):229-33. PubMed ID: 1489632
[TBL] [Abstract][Full Text] [Related]
27. Comparison of technetium-99m-HMPAO and xenon-133 measurements of regional cerebral blood flow by SPECT.
Payne JK; Trivedi MH; Devous MD
J Nucl Med; 1996 Oct; 37(10):1735-40. PubMed ID: 8862321
[TBL] [Abstract][Full Text] [Related]
28. Improvement of brain SPECT by stabilization of Tc-99m-HMPAO with methylene blue or cobalt chloride. Comparison with Tc-99m-ECD.
Barthel H; Kämpfer I; Seese A; Dannenberg C; Kluge R; Burchert W; Knapp WH
Nuklearmedizin; 1999 Apr; 38(3):80-4. PubMed ID: 10320993
[TBL] [Abstract][Full Text] [Related]
29. [Quantification of regional cerebral blood flow using 99mTc-HMPAO SPECT and intravenous 133Xe injection method].
Isaka Y; Iiji O; Imaizumi M; Ashida K; Itoi Y
Kaku Igaku; 1992 Dec; 29(12):1463-73. PubMed ID: 1491492
[TBL] [Abstract][Full Text] [Related]
30. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
Donnemiller E; Heilmann J; Wenning GK; Berger W; Decristoforo C; Moncayo R; Poewe W; Ransmayr G
Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472
[TBL] [Abstract][Full Text] [Related]
31. SPECT image analysis using statistical parametric mapping: comparison of technetium-99m-HMPAO and technetium-99m-ECD.
Patterson JC; Early TS; Martin A; Walker MZ; Russell JM; Villanueva-Meyer H
J Nucl Med; 1997 Nov; 38(11):1721-5. PubMed ID: 9374340
[TBL] [Abstract][Full Text] [Related]
32. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.
Léveillé J; Demonceau G; Walovitch RC
J Nucl Med; 1992 Apr; 33(4):480-4. PubMed ID: 1552328
[TBL] [Abstract][Full Text] [Related]
33. [Linealization correction for acetazolamide (Diamox) 99mTc-HMPAO SPECT image--a comparative study with PET].
Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
Kaku Igaku; 1994 Mar; 31(3):277-82. PubMed ID: 8176867
[TBL] [Abstract][Full Text] [Related]
34. Double-tracer SPECT in patients with AIDS encephalopathy: a comparison of 123I-IMP with 99Tcm-HMPAO.
Pohl P; Riccabona G; Hilty E; Deisenhammer F; Rösslér H; Zangerle R; Gerstenbrand F
Nucl Med Commun; 1992 Aug; 13(8):586-92. PubMed ID: 1513520
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of brain perfusion SPECT imaging using 99mTc-ECD].
Matsuda H; Kinuya K; Higashi S; Kawasaki Y; Sumiya H; Shuke N; Hisada K; Yamashita J; Yamaguchi N
Kaku Igaku; 1991 Jul; 28(7):701-9. PubMed ID: 1920946
[TBL] [Abstract][Full Text] [Related]
36. Brain perfusion SPECT in the mouse: normal pattern according to gender and age.
Apostolova I; Wunder A; Dirnagl U; Michel R; Stemmer N; Lukas M; Derlin T; Gregor-Mamoudou B; Goldschmidt J; Brenner W; Buchert R
Neuroimage; 2012 Dec; 63(4):1807-17. PubMed ID: 22971548
[TBL] [Abstract][Full Text] [Related]
37. [SPECT in reversible symptoms of cerebrovascular diseases].
Grünwald F; Broich K; Kropp J; Hartmann A; Biersack HJ
Nuklearmedizin; 1989 Dec; 28(6):221-5. PubMed ID: 2608445
[TBL] [Abstract][Full Text] [Related]
38. Intra-individual differences between technetium-99m-HMPAO and technetium-99m-ECD in the normal medial temporal lobe.
Oku N; Matsumoto M; Hashikawa K; Moriwaki H; Ishida M; Seike Y; Terakawa H; Watanabe Y; Uehara T; Nishimura T
J Nucl Med; 1997 Jul; 38(7):1109-11. PubMed ID: 9225799
[TBL] [Abstract][Full Text] [Related]
39. Comparison of I-123 IMP and Tc-99m HMPAO SPECT studies with PET in dementia.
Kuwabara Y; Ichiya Y; Otsuka M; Tahara T; Fukumura T; Gunasekera R; Ichimiya A; Masuda K
Ann Nucl Med; 1990 Nov; 4(3):75-82. PubMed ID: 2083138
[TBL] [Abstract][Full Text] [Related]
40. Comparison of [99mTc]HMPAO SPECT with [18F]fluoromethane PET in cerebrovascular disease.
Heiss WD; Herholz K; Podreka I; Neubauer I; Pietrzyk U
J Cereb Blood Flow Metab; 1990 Sep; 10(5):687-97. PubMed ID: 2384541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
